• Home
  • Media
  • Press Releases

Press Releases

Gulf Pharmaceutical Industries Julphar reports financial results for Q3 2023

2023-11-14
Julphar reports revenues of AED366 million in Q3 2023 with double digit growth development in its core market KSA    13th November, 2023, Ras Al Khaimah, UAE: Gulf Pharmaceutical Industries…

Gulf Pharmaceutical Industries 'Julphar' reports financial results for H1 2023

2023-08-11
· Julphar reports AED859.4 million in H1 2023, 2.5% increase year-on-year (+4.7% at constant currency), with solid growth development in UAE and across GCC region. · Over 86 million units…
Julphar Signs Landmark Agreement with Sunshine Lake Pharma to Pioneer Insulin Biosimilar Manufacturing in MENA

Gulf Pharmaceutical Industries 'Julphar' Signs Landmark Agreement with Sunshine Lake Pharma to Pioneer Insulin Biosimilar Manufacturing in MENA

2023-05-18
Julphar is set to become the first company to localize Insulin Biosimilars manufacturing in the MENA region. The agreement includes licensing and technology transfer for Insulin Glargine and Insulin Aspart…

Gulf Pharmaceutical Industries Julphar reports financial results for Q1 2023

2023-05-15
Julphar reports 8.5% increase in sales compared to Q1 2022 EBITDA reaches 10% of Net Sales in Q1 2023   May 2023, Ras Al Khaimah, UAE: Gulf Pharmaceutical Industries PJSC (Julphar), one of the largest…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.